0 followers
At Glaukos, their focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
Thomas W. Burns
Federal Housing Finance Agency
4 followers
Integra LifeSciences
6 followers
Charles River Development
4 followers
Stryker
121 followers
Boston Scientific
86 followers
Baxter
84 followers
Publicis Sapient
47 followers
Intuitive Surgical
41 followers
FactSet
36 followers
Univision
37 followers
Align Technology
29 followers
Explore companies